SNDX vs STOK Stock Comparison

SNDX currently leads STOK in this stock comparison, with AIQ scores of 43 vs 42. The clearest difference is value, while STOK has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
SNDX
Healthcare
vs
STOK
Healthcare
SNDX
Syndax Pharmaceuticals, Inc.
Leads
Price
$9.45
Day move
-0.94%
AIQ Score
43/100
Best edge
Value
Sector
Healthcare
STOK
Stoke Therapeutics, Inc.
Price
$26.68
Day move
+1.83%
AIQ Score
42/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between SNDX and STOK?

SNDX leads the current stock comparison as Syndax Pharmaceuticals, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Syndax Pharmaceuticals, Inc. vs Stoke Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

SNDX leads

SNDX leads by 1 AIQ points, primarily on Value and Quality, but the lead has narrowed from 7 points over 30 sessions.

Fragile: 2 of 6 evidence groups support SNDX, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 6Comparison trend: Weakening
SNDX

Syndax Pharmaceuticals, Inc.

Leads
AIQ Score
43/100
AIQ Edge Score
2/10
STOK

Stoke Therapeutics, Inc.

AIQ Score
42/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors SNDX over STOK, 43 versus 42 as of Nov 15, 2026. SNDX's advantage is driven primarily by stronger value and quality, while STOK holds the stronger momentum profile. SNDX also shows the weaker technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor SNDX today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. SNDX lead: Weakening — the AIQ differential moved from 7 to 1 points over 30 sessions.

Compare Syndax Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

SNDX
-47.0%
STOK
-5.4%

Price return comparison

Growth of $10,000, price only

SNDX $5,303 · STOK $9,461

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare SNDX and STOK against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

SNDX advantage
0
STOK advantage
  • Value64 vs 22
    SNDX +42
  • Momentum14 vs 47
    STOK +33
  • Quality66 vs 42
    SNDX +24
  • Risk Resilience37 vs 59
    STOK +22

2 of 6 evidence groups favor SNDX. SNDX’s edge is concentrated in value and quality; STOK keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

SNDX+1 AIQ

Largest factor move: Value +2

No signal started or stopped since the prior session; its 7 active signals are unchanged.

STOK0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon

SNDX's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — SNDX and STOK both carry a full feed there.

The central trade-off

SNDX (Syndax Pharmaceuticals, Inc.): the stronger current systematic profile, led by value and quality.

STOK (Stoke Therapeutics, Inc.): the counter-case, on momentum, risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

SNDX

SNDX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

SNDX

SNDX on combined revenue and EPS growth.

Value

SNDX

SNDX on the peer-relative Value factor, by 42 points.

Momentum

STOK

STOK on the Momentum factor, by 33 points.

Lower downside

STOK

STOK on Risk Resilience, by 22 points.

Analyst upside

SNDX

SNDX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureSNDXSTOKNote
Implied upside to target+288.9%+61.2%SNDX has more room
Target dispersion+27.2%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1214Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 6 covered evidence groups favor SNDX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven43 vs 42
FundamentalsEvenrevenue growth 14.4% vs 20.7%; TTM ROE 287.7% vs -20.9%; gross margin 93.7% vs 88.5%; operating margin -61.7% vs -9.1%
ValuationSNDXValue 64 vs 22
TechnicalsSTOKPrice vs 50-day -38.1% vs 0.9%; vs 200-day -52.1% vs -13.3%
Risk ResilienceSTOKRisk Resilience 37 vs 59
Analyst expectationsSNDXTarget upside 288.9% vs 61.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of SNDX and STOK and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)
  • Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SNDX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

SNDX lead: Weakening — the AIQ differential moved from 7 to 1 points over 30 sessions.

May 27SNDX leads above the line · STOK leads belowNov 13
Today
SNDX +1
43 vs 42
7 sessions ago
SNDX +4
44 vs 40
30 sessions ago
SNDX +7
43 vs 36
90 sessions ago
SNDX +9
53 vs 44

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

SNDXConflicted

1 bullish / 4 bearish / 2 neutral, conflicted

Only SNDX

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold — bullish, momentum, short horizon
STOKConflicted

3 bullish / 2 bearish / 2 neutral, conflicted

Only STOK

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.31x)
  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.

SNDX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

SNDXDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.94%, AIQ +1 points).

STOKNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.83%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1STOK closes the Value gap — currently 42 points behind, the largest single contributor to SNDX's edge.
  2. 2STOK's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3SNDX's conflicting signal state resolves bearish — it currently carries 1 bullish and 4 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 1-point move would eliminate SNDX's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricSNDXSTOK
Revenue growth (YoY)14.4%20.7%
EPS growth (YoY)0%-16.1%
Gross margin93.7%88.5%
Operating margin-61.7%-9.1%
Return on equity (TTM)287.7%-20.9%
Debt to equity-34.310

Performance

STOK leads 6 of 6 windows
MetricSNDXSTOK
1 week (5 sessions)-0.9%0.5%
1 month (20 sessions)-26.7%10.4%
3 months (63 sessions)-52.2%-17%
6 months (126 sessions)-53.3%-11.3%
Year to date-55%-15.9%
1 year (252 sessions)-43.7%6.2%

Technicals

STOK has the stronger structure
MetricSNDXSTOK
RSI (14)26.251.3
ADX (14)47.717.3
Price vs 50-day-38.1%0.9%
Price vs 200-day-52.1%-13.3%
Volatility (1M, annualized)113.3%48.9%

Risk

STOK is the more resilient
MetricSNDXSTOK
Beta0.770.96
Sharpe ratio-0.760.23
Sortino ratio-0.970.35
Max drawdown-62.7%-41.3%
Current drawdown-62.4%-30.4%
Annualized volatility57.2%53.2%
Value at risk (95%)-4.5%-5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, SNDX or STOK?

On the Algovestiq AIQ Score, SNDX is the stronger of the two as of Nov 15, 2026, scoring 43 against STOK's 42. The edge comes from value and quality. STOK is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is SNDX or STOK the better buy right now?

SNDX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor SNDX over STOK?

The composite weights Quality, Value, Momentum and Risk Resilience. SNDX leads Value by 42 points; STOK leads Momentum by 33 points; SNDX leads Quality by 24 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, SNDX or STOK?

Analyst price targets imply +288.9% upside for SNDX and +61.2% for STOK, so the Street currently favors SNDX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, SNDX or STOK?

SNDX is the better-valued of the two on the peer-relative Value factor. SNDX on the peer-relative Value factor, by 42 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, SNDX or STOK?

SNDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, SNDX or STOK?

STOK on the Momentum factor, by 33 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, SNDX or STOK?

STOK is the more resilient of the two, so the other name carries the higher downside risk. STOK on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is SNDX more profitable than STOK?

The profitability evidence is mixed: gross margin 93.7% vs 88.5%; operating margin -61.7% vs -9.1%; ttm roe 287.7% vs -20.9%. SNDX leads on two measures and STOK on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is SNDX's lead over STOK getting stronger or weaker?

SNDX lead: Weakening — the AIQ differential moved from 7 to 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the SNDX vs STOK verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: STOK closes the Value gap — currently 42 points behind, the largest single contributor to SNDX's edge; STOK's Death Cross Active resolves — a bearish trend rule currently active against it; SNDX's conflicting signal state resolves bearish — it currently carries 1 bullish and 4 bearish rules at once; the narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 1-point move would eliminate SNDX's advantage entirely.

What do the current signals say about SNDX and STOK?

SNDX: 1 bullish / 4 bearish / 2 neutral, conflicted. STOK: 3 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on SNDX is Death Cross Active (bearish, long horizon). On STOK it is Death Cross Active (bearish, long horizon).

Compare SNDX and STOK with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.